| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Original Research Communication |
1 From the Valio, Ltd, Research Center, Helsinki (LS, TJ, and RK); Stat-Consulting, Tampere, Finland (TP); the Foundation for Nutrition Research, Helsinki (RK); and the Institute of Biomedicine, University of Helsinki (TJ and RK).
Background: Angiotensin-converting enzyme (ACE; EC 3.4.15.1) plays a dual role in the regulation of hypertension: it catalyzes the production of the vasoconstrictor angiotensin II and it inactivates the vasodilator bradykinin. By inhibiting these processes, ACE inhibitors have antihypertensive effects. Peptides derived from milk proteins can have ACE-inhibiting properties and may thus be used as antihypertensive components.
Objective: We evaluated the long-term blood pressure–lowering effect of milk fermented by Lactobacillus helveticus LBK-16H in hypertensive subjects.
Design: In a randomized placebo-controlled study, 39 hypertensive patients received 150 mL/d of either L. helveticus LBK-16H fermented milk or a control product for 21 wk after a 2-wk run-in period. During the run-in period, the average baseline diastolic and systolic blood pressure values were 155 and 97 mm Hg, respectively, in the test product group and 152 and 96 mm Hg, respectively, in the control group. After the run-in period, blood pressure was measured at home on the same day every week with the use of an automatic blood pressure recorder.
Results: There was a mean difference of 6.7 ± 3.0 mm Hg in systolic blood pressure (P = 0.030) and of 3.6 ± 1.9 mm Hg (P = 0.059) in diastolic blood pressure between the test product and control groups. Demographic factors had no significant effect on the responses.
Conclusion: L. helveticus LBK-16H fermented milk containing bioactive peptides in normal daily use has a blood pressure–lowering effect in hypertensive subjects.
Key Words: Fermented milk • bioactive peptides • blood pressure • Lactobacillus helveticus • hypertension • valine-proline-proline • isoleusine-proline-proline • angiotensin-converting enzyme inhibitors
This article has been cited by other articles:
|
|
 |
|
  M. Genay, L. Sadat, V. Gagnaire, and S. Lortal prtH2, Not prtH, Is the Ubiquitous Cell Wall Proteinase Gene in Lactobacillus helveticus Appl. Envir. Microbiol., May 15, 2009; 75(10): 3238 - 3249. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Weimann, H. Meisel, and G. Erhardt Short communication: Bovine {kappa}-casein variants result in different angiotensin I converting enzyme (ACE) inhibitory peptides J Dairy Sci, May 1, 2009; 92(5): 1885 - 1888. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Meyer, U. Butikofer, B. Walther, D. Wechsler, and R. Sieber Hot topic: Changes in angiotensin-converting enzyme inhibition and concentrations of the tripeptides Val-Pro-Pro and Ile-Pro-Pro during ripening of different Swiss cheese varieties J Dairy Sci, March 1, 2009; 92(3): 826 - 836. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. van Mierlo, M. M. Koning, K. van der Zander, and R. Draijer Lactotripeptides do not lower ambulatory blood pressure in untreated whites: results from 2 controlled multicenter crossover studies Am. J. Clinical Nutrition, February 1, 2009; 89(2): 617 - 623. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. van der Zander, M. L Bots, A. A. Bak, M. M. Koning, and P. W de Leeuw Enzymatically hydrolyzed lactotripeptides do not lower blood pressure in mildly hypertensive subjects Am. J. Clinical Nutrition, December 1, 2008; 88(6): 1697 - 1702. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. F. Engberink, E. G. Schouten, F. J. Kok, L. A.J. van Mierlo, I. A. Brouwer, and J. M. Geleijnse Lactotripeptides Show No Effect on Human Blood Pressure: Results From a Double-Blind Randomized Controlled Trial Hypertension, February 1, 2008; 51(2): 399 - 405. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Butikofer, J. Meyer, R. Sieber, B. Walther, and D. Wechsler Occurrence of the Angiotensin-Converting Enzyme-Inhibiting Tripeptides Val-Pro-Pro and Ile-Pro-Pro in Different Cheese Varieties of Swiss Origin J Dairy Sci, January 1, 2008; 91(1): 29 - 38. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. Heimann, I. Gomes, C. S. Dale, R. L. Pagano, A. Gupta, L. L. de Souza, A. D. Luchessi, L. M. Castro, R. Giorgi, V. Rioli, et al. Hemopressin is an inverse agonist of CB1 cannabinoid receptors PNAS, December 18, 2007; 104(51): 20588 - 20593. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Foltz, E. E. Meynen, V. Bianco, C. van Platerink, T. M. M. G. Koning, and J. Kloek Angiotensin Converting Enzyme Inhibitory Peptides from a Lactotripeptide-Enriched Milk Beverage Are Absorbed Intact into the Circulation J. Nutr., April 1, 2007; 137(4): 953 - 958. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Jauhiainen and R. Korpela Milk Peptides and Blood Pressure J. Nutr., March 1, 2007; 137(3): 825S - 829S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Quiros, M. Ramos, B. Muguerza, M. A. Delgado, P. J. Martin-Alvarez, A. Aleixandre, and I. Recio Determination of the Antihypertensive Peptide LHLPLP in Fermented Milk by High-Performance Liquid Chromatography-Mass Spectrometry J Dairy Sci, December 1, 2006; 89(12): 4527 - 4535. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Scolari, M. Vescovo, C. Zacconi, and F. Vescovi Extraction and Partial Characterization of Proteolytic Activities from the Cell Surface of Lactobacillus helveticus Zuc2. J Dairy Sci, October 1, 2006; 89(10): 3800 - 3809. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Geerlings, I. C. Villar, F. H. Zarco, M. Sanchez, R. Vera, A. Z. Gomez, J. Boza, and J. Duarte Identification and characterization of novel Angiotensin-converting enzyme inhibitors obtained from goat milk. J Dairy Sci, September 1, 2006; 89(9): 3326 - 3335. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Miguel, I. Recio, M. Ramos, M. A. Delgado, and M. A. Aleixandre Antihypertensive Effect of Peptides Obtained from Enterococcus faecalis-Fermented Milk in Rats. J Dairy Sci, September 1, 2006; 89(9): 3352 - 3359. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Aihara, O. Kajimoto, H. Hirata, R. Takahashi, and Y. Nakamura Effect of Powdered Fermented Milk with Lactobacillus helveticus on Subjects with High-Normal Blood Pressure or Mild Hypertension J. Am. Coll. Nutr., August 1, 2005; 24(4): 257 - 265. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. K. Bernard, Y. Nakamura, I. Bando, and J. H. Mennear Studies of the Toxicological Potential of Tripeptides (L-Valyl-L-prolyl-L-proline and L-Isoleucyl-L-prolyl-L-proline): II. Introduction International Journal of Toxicology, July 1, 2005; 24(4_suppl): 5 - 11. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. Neuspiel Dietary Fruit, Vegetable, and Dairy Intake Leads to Lasting Blood Pressure Changes AAP Grand Rounds, May 1, 2005; 13(5): 58 - 58. [Full Text] [PDF]
|
|
|
|
|
|
D. J. Walsh, H. Bernard, B. A. Murray, J. MacDonald, A.-K. Pentzien, G. A. Wright, J.-M. Wal, A. D. Struthers, H. Meisel, and R. J. FitzGerald In Vitro Generation and Stability of the Lactokinin {beta}-Lactoglobulin Fragment (142-148) J Dairy Sci, November 1, 2004; 87(11): 3845 - 3857. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Psaltopoulou, A. Naska, P. Orfanos, D. Trichopoulos, T. Mountokalakis, and A. Trichopoulou Olive oil, the Mediterranean diet, and arterial blood pressure: the Greek European Prospective Investigation into Cancer and Nutrition (EPIC) study Am. J. Clinical Nutrition, October 1, 2004; 80(4): 1012 - 1018. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Murakami, H. Tonouchi, R. Takahashi, H. Kitazawa, Y. Kawai, H. Negishi, and T. Saito Structural Analysis of a New Anti-Hypertensive Peptide ({beta}-Lactosin B) Isolated from a Commercial Whey Product J Dairy Sci, July 1, 2004; 87(7): 1967 - 1974. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. FitzGerald, B. A. Murray, and D. J. Walsh Hypotensive Peptides from Milk Proteins J. Nutr., April 1, 2004; 134(4): 980S - 988S. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
